Targeting non-coding RNAs to overcome cancer therapy resistance

BQ Chen, MP Dragomir, C Yang, Q Li, D Horst… - Signal transduction and …, 2022 - nature.com
It is now well known that non-coding RNAs (ncRNAs), rather than protein-coding transcripts,
are the preponderant RNA transcripts. NcRNAs, particularly microRNAs (miRNAs), long non …

[HTML][HTML] miRNA-based biomarkers, therapies, and resistance in Cancer

B He, Z Zhao, Q Cai, Y Zhang, P Zhang… - … journal of biological …, 2020 - ncbi.nlm.nih.gov
Abstract MicroRNAs (miRNAs), small non-coding RNAs (ncRNAs) of about 22 nucleotides in
size, play important roles in gene regulation, and their dysregulation is implicated in human …

Comprehensive analysis of microRNA (miRNA) in cancer cells

N Kanwal, OR Al Samarrai, HMH Al-Zaidi… - Cellular, Molecular …, 2023 - cmbr-journal.com
MicroRNAs (miRNA) are a group of small non-coding RNAs that regulate gene expression
at the RNA level. MicroRNAs have positive regulatory effects on protein translation …

miRNAs as potential game-changers in head and neck cancer: Future clinical and medicinal uses

HA El-Mahdy, AM Mohamadin, AI Abulsoud… - … -Research and Practice, 2023 - Elsevier
Head and neck cancers (HNCs) are a group of heterogeneous tumors formed most
frequently from epithelial cells of the larynx, lips, oropharynx, nasopharynx, and mouth …

The role of cancer-derived microRNAs in cancer immune escape

M Yi, L Xu, Y Jiao, S Luo, A Li, K Wu - Journal of hematology & oncology, 2020 - Springer
During malignant transformation, accumulated somatic mutations endow cancer cells with
increased invasiveness and immunogenicity. Under selective pressure, these highly …

RNA-mediated immunotherapy regulating tumor immune microenvironment: next wave of cancer therapeutics

PR Pandey, KH Young, D Kumar, N Jain - Molecular cancer, 2022 - Springer
Accumulating research suggests that the tumor immune microenvironment (TIME) plays an
essential role in regulation of tumor growth and metastasis. The cellular and molecular …

[HTML][HTML] MALAT-1: Immunomodulatory lncRNA hampering the innate and the adaptive immune arms in triple negative breast cancer

RY Mekky, MF Ragab, T Manie, AA Attia… - Translational …, 2023 - Elsevier
Background Triple negative breast cancer (TNBC) is known as hot immunogenic tumor. Yet,
it is one of the most aggressive BC subtypes. TNBC evolve several tactics to evade the …

Targeting of the tumor immune microenvironment by metformin

Z Wu, C Zhang, M Najafi - Journal of cell communication and signaling, 2022 - Springer
Stimulating antitumor immunity is an attractive idea for suppressing tumors. CD4+ and CD8+
T cells as well as natural killer cells (NK) are the primary antitumor immune cells in the tumor …

Immune checkpoint molecules—Inherited variations as markers for cancer risk

M Wagner, M Jasek, L Karabon - Frontiers in immunology, 2021 - frontiersin.org
In recent years, immunotherapy has been revolutionized by a new approach that works by
blocking receptors called immune checkpoints (IC). These molecules play a key role in …

The anticancer effects of flavonoids through miRNAs modulations in triple-negative breast cancer

GM Adinew, E Taka, P Mendonca, SS Messeha… - Nutrients, 2021 - mdpi.com
Triple-negative breast cancer (TNBC) incidence rate has regularly risen over the last
decades and is expected to increase in the future. Finding novel treatment options with …